HUS,Töölö hospital
Helsinki, 00290, Finland
NCT Number: NCT05269836
Purpose of the study: To evaluate whether the SSB is safe, useful, beneficial and effective in drilling, cutting and removal of bone tissue in neurosurgical and spine procedures.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Helsinki, 00290, Finland
Sponsored observational clinical pilot study with no control group. Aim is to get a maximum of 20 study subjects, who have disease of the spine or head requiring surgery with bone removal and who are willing to participate into this study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use of Surgify Safety Burr in hard tissue cutting, head and spine area
Time frame: Duration is from recruitment until end of the time on recovery ward, approximately 1 day to 1 week.
Using video material from operations, microphone recording of the surgeon commentary during drilling and questionnaires to surgeon.
Time frame: Duration is from recruitment until end of the time on recovery ward, approximately 1 day to 1 week.
AE reporting
Time frame: Duration is from recruitment until end of the time on recovery ward, approximately 1 day to 1 week.
Using video material from operations, microphone recording of the surgeon commentary during drilling
Time frame: Duration is from recruitment until end of the time on recovery ward, approximately 1 day to 1 week
Questionnaires to surgeon
Surgify Medical Oy
Industry
Surgify2021. Use of Surgify Safety Burr in Hard Tissue Cutting, Head and Spine Area.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05887375
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Columbia, Missouri, United States
View Trial DetailsNCT06210061
Dexmedetomidine, Fentanyl
Cairo, Egypt
View Trial DetailsNCT02606695
Spine Surgery
La Jolla, California, United States
View Trial DetailsNCT04473508
AdverseEvent, Morphine
Nîmes, Gard, France
View Trial Details